Targeting natural products against SARS-CoV-2
2022
Al-Harrasi, Ahmed | Behl, Tapan | Upadhyay, Tanuj | Chigurupati, Sridevi | Bhatt, Shvetank | Sehgal, Aayush | Bhatia, Saurabh | Singh, Sukhbir | Sharma, Neelam | Vijayabalan, Shantini | Palanimuthu, Vasanth Raj | Das, Suprava | Rajwinder Kaur, | Aleya, Lotfi | Bungau, Simona
The human coronavirus disease (COVID-19) pandemic is caused by a novel coronavirus; the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2). Natural products, secondary metabolites show positive leads with antiviral and immunotherapy treatments using genomic studies in silico docking. In addition, it includes the action of a mechanism targeting the SARS-CoV-2. In this literature, we aimed to evaluate the antiviral movement of the NT-VRL-1 unique terpene definition to Human coronavirus (HCoV-229E). The effects of 19 hydrolysable tannins on the SARS-CoV-2 were therefore theoretically reviewed and analyzed utilising the molecular operating surroundings for their C-Like protease 3CLpro catalytic dyad residues Angiotensin converting enzyme-2 (MOE 09). Pedunculagin, tercatan, and castalin were detected as interacting strongly with SARS-receptor Cov-2’s binding site and catalytic dyad (Cys145 and His41). SARS-CoV-2 methods of subunit S1 (ACE2) inhibit the interaction of the receiver with the s-protein once a drug molecule is coupled to the s-protein and prevent it from infecting the target cells in alkaloids. Our review strongly demonstrates the evidence that natural compounds and their derivatives can be used against the human coronavirus and serves as an area of research for future perspective.
显示更多 [+] 显示较少 [-]